Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The proline-rich region of 18.5-kDa myelin basic protein binds to the SH3-domain of Fyn tyrosine kinase with the aid of an upstream segment to form a dynamic complex in vitro.
Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells.
Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods.
Experimental autoimmune encephalomyelitis.
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Treatment of neuromyelitis optica.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Evidence for the Importance of Vitamin D Status in Neurologic Conditions.
Mapping search terms to review goals is essential.
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.
7(th) International Immunoglobulin Conference: Interlaken Leadership Awards.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
Complex I Subunit Gene Therapy with NDUFA6 Ameliorates Neurodegeneration in EAE.
Time-to-Contact Analysis of Gait Stability in the Swing Phase of Walking in People With Multiple Sclerosis.
Magnetic susceptibility contrast variations in multiple sclerosis lesions.
Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.
Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.
Modulation of the Left Prefrontal Cortex with High Frequency Repetitive Transcranial Magnetic Stimulation Facilitates Gait in Multiple Sclerosis.
Exosomes as new diagnostic tools in CNS diseases.
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
Pages
« first
‹ previous
…
616
617
618
619
620
621
622
623
624
…
next ›
last »